Log in to save to my catalogue

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c9d019d611994e5cb582be3f41cb6a8b

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

About this item

Full title

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-06, Vol.12 (1), p.3615-3615, Article 3615

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Glioblastoma is considered one of the most aggressive malignancies in adult and pediatric patients. Despite decades of research no curative treatment is available and it thus remains associated with a very dismal prognosis. Although recent pre-clinical and clinical studies have demonstrated the feasibility of chimeric antigen receptors (CAR) T cell...

Alternative Titles

Full title

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c9d019d611994e5cb582be3f41cb6a8b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c9d019d611994e5cb582be3f41cb6a8b

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-23817-2

How to access this item